Evolent Health, Inc. (EVH) - Comprehensive Stock Analysis & Investment Research
Deep dive into Evolent Health, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Evolent Health, Inc. Investment Summary
When evaluating whether Evolent Health, Inc. (EVH) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Evolent Health, Inc. (EVH) operates within the Trade & Services sector, specifically in the Services-Management Services industry. The company employs approximately 2,663 people. With a market capitalization of $345 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.
Financial Performance Analysis
Our comprehensive financial analysis covers Evolent Health, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Evolent Health, Inc. along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Evolent Health, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Evolent Health, Inc. (Stock Symbol: EVH) is a prominent company operating within the Trade & Services sector, with a specific focus on the Services-Management Services industry. The company's shares are publicly traded on the NYSE exchange.
Leadership & Workforce
Detailed information about Evolent Health, Inc.'s leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Evolent Health, Inc....
Sector & Industry Analysis
In-depth sector dynamics and industry context for Evolent Health, Inc....
Revenue & Growth Analysis
Evolent Health, Inc. generates annual revenues of $2 billion , indicating a well-established business with proven market demand.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Evolent Health, Inc....
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Evolent Health, Inc....
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Evolent Health, Inc....
Strategic Market Position
Evolent Health, Inc. strategically competes in the highly dynamic Services-Management Services marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.
Industry Competitive Landscape
Evolent Health, Inc. competes within the Trade & Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company shows positive operational efficiency through free cash flow generation of $2 million annually . Positive free cash flow indicates the business generates more cash than required for operations and capital investments, providing resources for growth initiatives or shareholder returns.
Margin & Pricing Power Analysis
The company maintains a 133.5% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.
Operating margin of -19.4% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.
Asset Utilization Efficiency
Asset turnover ratio of 0.75x indicates moderate asset turnover common in capital-intensive industries such as utilities, real estate, or heavy manufacturing. Lower turnover in these sectors is expected due to the significant infrastructure required for operations.
Financial Strength & Leverage
Current ratio of 1.21 indicates adequate liquidity to meet short-term obligations with reasonable cushion. This level balances working capital efficiency with financial safety.